Dorman Products (DORM) Reports In-Line Q1 EPS, Offers Guidance
Get Alerts DORM Hot Sheet
Join SI Premium – FREE
Dorman Products (NASDAQ: DORM) reported Q1 EPS of $1.04, in-line with the analyst estimate of $1.04. Revenue for the quarter came in at $288 million versus the consensus estimate of $292 million.
GUIDANCE:
Dorman Products sees FY2021 EPS of $4.40-$4.60, versus the consensus of $4.49.
- For fiscal 2021, the Company expects net sales growth between 9%-12%, diluted EPS of between $4.32 and $4.52, and adjusted diluted EPS* of between $4.40 and $4.60.
For earnings history and earnings-related data on Dorman Products (DORM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- American Financial Group (AFG) Tops Q3 EPS by 19c, Beats on Revenue
- Phoenix Education Partners, Inc. (PXED) Misses Q4 EPS by 44c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share